Institutional investors purchased a net $133.7 million shares of ABBV during the quarter ended December 2014 and now own 71.98% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EGERTON CAPITAL (UK) LLP Bought 3.9 Million shares of AbbVie
D. E. SHAW & CO. LP Bought 3.4 Million shares of AbbVie
MASSACHUSETTS FINANCIAL SERVICES... Bought 3.0 Million shares of AbbVie